NCT06249802View on ClinicalTrials.gov

Beta-blockade in Unruptured Intracranial Aneurysm

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2029

Study Completion Date

January 1, 2030

Conditions
Intracranial Aneurysm
Interventions
DRUG

Nebivolol

12-month intake of medication

DRUG

Placebo

12-month intake of matching placebo

Trial Locations (1)

30-688

University Hospital in Krakow, Krakow

All Listed Sponsors
collaborator

University Hospital in Krakow

OTHER

lead

Jagiellonian University

OTHER